Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-20-000852
Filing Date
2020-01-08
Accepted
2020-01-08 20:31:26
Documents
1
Period of Report
2020-01-06

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3920
  Complete submission text file 0000899243-20-000852.txt   5440
Mailing Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660
Business Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660 360-980-8524
CytoDyn Inc. (Issuer) CIK: 0001175680 (see all company filings)

EIN.: 753056237 | State of Incorp.: DE | Fiscal Year End: 0531
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CYTODYN INC. 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660
Business Address
Fleming Maura (Reporting) CIK: 0001798921 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-49908 | Film No.: 20516872